2022年1月11日,

微創手術減少恢複時間,展示了新的機遇在門診醫療下載斯蒂芬·j·霍恩博士血管保健集團Leominster(照片:業務線)1月11日,2022年東部標準時間上午10:45 Leominster,質量。——(業務線)——血管治療組(TVCG),一個先進的實踐致力於預防、診斷和治療的血管疾病,今天宣布Stephen j .洪尼格醫學博士成功完成經皮femoral-popliteal Leominster動脈搭橋,質量。TVCG的位置,標記的第一個此類程序的門診。TVCG周圍集中處理模式優化病人的經驗,提供先進的血管介入傳統的醫院外設置,和減輕不必要的費用。這種尖端的成功,微創手術標誌著另一個任務的一步。過程是一個臨床實驗裝置的一部分豁免(IDE)試驗稱為DETOUR2繼續訪問(NCT04625660),由Endologix LLC。試驗的安全性和有效性評價的PQ旁路係統經皮femoral-popliteal搭橋手術。PQ旁路係統指定為美國食品和藥物管理局(FDA)在2020年突破設備。“通過提供這種類型的微創手術在門診,我們可以幫助患者避免手術切口,住院治療和術後恢複,”霍恩博士說。“病人出院過程兩個小時後沒有不適,隻有兩個小,英寸的切口的訪問。這顯然改變了我們肢體威脅疾病的方法。 I feel privileged to be one of the first vascular surgeons in Massachusetts to perform the procedure.” Dr. Hoenig performed the procedure in his Leominster vascular center. The patient was placed under light conscious sedation and was sent home to recover a few hours later. This advancement in treatment was performed in concert with Vascular Breakthroughs, a clinical trials management platform. "This is an impressive achievement for both Dr. Hoenig and The Vascular Care Group,” said Dr. Paul Gagne, founder of Vascular Breakthroughs, the clinical trials research organization supporting Dr. Hoenig. “The procedure expands the possibilities of vascular care in the outpatient setting and provides patients with better outcomes in a patient-friendly environment.” The percutaneous bypass graft is used to restore blood flow to the lower leg and foot using a minimally invasive technique that avoids hospitalization and long recovery. With this new procedure, The Vascular Care Group is providing new technologies and techniques to community physicians working outside of large research centers, enabling greater access to medical innovation in a safe, efficient, patient-friendly setting. It marks another step in granting communities access to cutting-edge technology on a local level at a lower cost, without requiring a trip to a major city, or a long hospital stay. The PQ Bypass System is limited by federal law to investigational use only and is not available for sale. About The Vascular Care Group The Vascular Care Group (TVCG) is a growing group practice committed to the prevention, diagnosis, and treatment of vascular disease. The practice brings together decades of expertise among a team of vascular specialists offering unparalleled care in Massachusetts at four full-service vascular care centers with five satellite offices, from Worcester to Cape Cod. Their comprehensive services cover a broad range of conditions from non-invasive vascular testing to complex vascular surgeries, including a full spectrum of open and endovascular procedures performed in-office and at affiliated hospitals throughout the state. The care center has united some of the area’s leading vascular experts with a focus on superior patient care. More information about the practice can be found at https://vascularcaregrp.com/ . About Vascular Breakthroughs Vascular Breakthroughs was founded by Paul J. Gagne MD, FACS, RVT in 2012 to provide a research infrastructure for physicians not affiliated with an academic institution. The organization has put new technologies in the hands of physicians working in the community, thereby improving access to novel treatments for patients and expanding the reach of cutting-edge research. Vascular Breakthroughs provides administrative support for all aspects of the implementation of a clinical trial, including recruitment, all phases in the initiation of a new trial and in the execution of a trial. More information about Vascular Breakthroughs can be found at https://vascularbreakthroughs.com/ . Contacts